Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CytoVive is a specialized biotechnology company that provides advanced optical imaging solutions designed for nanoscale research. The company's core technology is an enhanced darkfield hyperspectral microscopy platform that allows researchers to observe and characterize nanomaterials and pathogens in real-time without the need for fluorescent labeling. This technology is widely utilized in the development of drug delivery systems, particularly for tracking the interaction of nanoparticles with live cells. CytoVive's solutions are employed by leading academic institutions, government research labs, and pharmaceutical companies globally to advance fields such as oncology, infectious disease, and material science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CytoVive.